DMBA promotes ErbB2‑mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability

Ma,Zhikun; Kim,Young Mi; Howard,Erin W.; Feng,Xiaoshan; Kosanke,Stanley D.; Yang,Shihe; Jiang,Yunbo; Parris,Amanda B.; Cao,Xia; Li,Shibo; Yang,Xiaohe

doi:10.3892/or.2018.6545

DMBA promotes ErbB2‑mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability

Authors:
- Zhikun Ma
- Young Mi Kim
- Erin W. Howard
- Xiaoshan Feng
- Stanley D. Kosanke
- Shihe Yang
- Yunbo Jiang
- Amanda B. Parris
- Xia Cao
- Shibo Li
- Xiaohe Yang
View Affiliations

Affiliations: Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma, OK 73104, USA, Julius L. Chambers Biomedical/Biotechnology Research Institute, Department of Biological and Biomedical Sciences, North Carolina Central University, North Carolina Research Campus, Kannapolis, NC 28081, USA, Department of Oncology, First Affiliated Hospital of Henan University of Sciences and Technology, Luoyang, Henan 471500, P.R. China
Published online on: July 4, 2018 https://doi.org/10.3892/or.2018.6545
Pages: 1632-1640

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Environmental factors, including 7,12‑dimethylbenz[a]anthracene (DMBA) exposure, and genetic predisposition, including ErbB2 overexpression/amplification, have been demonstrated to increase breast cancer susceptibility. Although DMBA‑ and ErbB2‑mediated breast cancers are well‑studied in their respective models, key interactions between environmental and genetic factors on breast cancer risk remain unclear. Therefore, the present study aimed to investigate the effect of DMBA exposure on ErbB2‑mediated mammary tumorigenesis. MMTV‑ErbB2 transgenic mice exposed to DMBA (1 mg) via weekly oral gavage for 6 weeks exhibited significantly enhanced mammary tumor development, as indicated by reduced tumor latency and increased tumor multiplicity compared with control mice. Whole mount analysis of premalignant mammary tissues from 15‑week‑old mice revealed increased ductal elongation and proliferative index in DMBA‑exposed mice. Molecular analyses of premalignant mammary tissues further indicated that DMBA exposure enhanced epidermal growth factor receptor (EGFR)/ErbB2 and estrogen receptor (ER) signaling, which was associated with increased mRNA levels of EGFR/ErbB2 family members and ER‑targeted genes. Furthermore, analysis of tumor karyotypes revealed that DMBA‑exposed tumors displayed more chromosomal alterations compared with control tumors, implicating DMBA‑induced chromosomal instability in tumor promotion in this model. Together, the data suggested that DMBA‑induced deregulation of EGFR/ErbB2‑ER pathways plays a critical role in the enhanced chromosomal instability and promotion of ErbB2‑mediated mammary tumorigenesis. The study highlighted gene‑environment interactions that may increase risk of breast cancer, which is a critical clinical issue.

View Figures

View References

1	Nowell SA, Ahn J and Ambrosone CB: Gene-nutrient interactions in cancer etiology. Nutr Rev. 62:427–438. 2004. View Article : Google Scholar : PubMed/NCBI
2	Song M, Lee KM and Kang D: Breast cancer prevention based on gene-environment interaction. Mol Carcinog. 50:280–290. 2011. View Article : Google Scholar : PubMed/NCBI
3	Chia KS: Gene-environment interactions in breast cancer. Novartis Found Symp. 293:143–150; discussion 150–155, 181–183. 2008. View Article : Google Scholar : PubMed/NCBI
4	Rubin BS: Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol. 127:27–34. 2011. View Article : Google Scholar : PubMed/NCBI
5	Belpomme D, Irigaray P, Hardell L, Clapp R, Montagnier L, Epstein S and Sasco AJ: The multitude and diversity of environmental carcinogens. Environ Res. 105:414–429. 2007. View Article : Google Scholar : PubMed/NCBI
6	Schell LM, Burnitz KK and Lathrop PW: Pollution and human biology. Ann Hum Biol. 37:347–366. 2010. View Article : Google Scholar : PubMed/NCBI
7	Majkova Z, Toborek M and Hennig B: The role of caveolae in endothelial cell dysfunction with a focus on nutrition and environmental toxicants. J Cell Mol Med. 14:2359–2370. 2010. View Article : Google Scholar : PubMed/NCBI
8	Rybicki BA, Nock NL, Savera AT, Tang D and Rundle A: Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis. Cancer Lett. 239:157–167. 2006. View Article : Google Scholar : PubMed/NCBI
9	Singhal R, Shankar K, Badger TM and Ronis MJ: Estrogenic status modulates aryl hydrocarbon receptor-mediated hepatic gene expression and carcinogenicity. Carcinogenesis. 29:227–236. 2008. View Article : Google Scholar : PubMed/NCBI
10	Mehta RG, Naithani R, Huma L, Hawthorne M, Moriarty RM, McCormick DL, Steele VE and Kopelovich L: Efficacy of chemopreventive agents in mouse mammary gland organ culture (MMOC) model: A comprehensive review. Curr Med Chem. 15:2785–2825. 2008. View Article : Google Scholar : PubMed/NCBI
11	Currier N, Solomon SE, Demicco EG, Chang DL, Farago M, Ying H, Dominguez I, Sonenshein GE, Cardiff RD, Xiao ZX, et al: Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol Pathol. 33:726–737. 2005. View Article : Google Scholar : PubMed/NCBI
12	Nebert DW, Petersen DD and Fornace AJ Jr: Cellular responses to oxidative stress: The [Ah] gene battery as a paradigm. Environ Health Perspect. 88:13–25. 1990. View Article : Google Scholar : PubMed/NCBI
13	Rundle A, Tang D, Hibshoosh H, Estabrook A, Schnabel F, Cao W, Grumet S and Perera FP: The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis. 21:1281–1289. 2000. View Article : Google Scholar : PubMed/NCBI
14	Papaconstantinou AD, Shanmugam I, Shan L, Schroeder IS, Qiu C, Yu M and Snyderwine EG: Gene expression profiling in the mammary gland of rats treated with 7,12-dimethylbenz[a]anthracene. Int J Cancer. 118:17–24. 2006. View Article : Google Scholar : PubMed/NCBI
15	Liu E, Thor A, He M, Barcos M, Ljung BM and Benz C: The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene. 7:1027–1032. 1992.PubMed/NCBI
16	Jardines L, Weiss M and Fowble B: Greene Mneu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer. Pathobiology. 61:268–282. 1993. View Article : Google Scholar : PubMed/NCBI
17	Hynes NE and Stern DF: The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta. 1198:165–184. 1994.PubMed/NCBI
18	Citri A and Yarden Y: EGF-ERBB signalling: Towards the systems level. Nat Rev Mol Cell Biol. 7:505–516. 2006. View Article : Google Scholar : PubMed/NCBI
19	Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD and Muller WJ: Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA. 89:10578–10582. 1992. View Article : Google Scholar : PubMed/NCBI
20	Bouchard L, Lamarre L, Tremblay PJ and Jolicoeur P: Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell. 57:931–936. 1989. View Article : Google Scholar : PubMed/NCBI
21	Marcotte R and Muller WJ: Signal transduction in transgenic mouse models of human breast cancer-implications for human breast cancer. J Mammary Gland Biol Neoplasia. 13:323–335. 2008. View Article : Google Scholar : PubMed/NCBI
22	Hutchinson JN and Muller WJ: Transgenic mouse models of human breast cancer. Oncogene. 19:6130–6137. 2000. View Article : Google Scholar : PubMed/NCBI
23	Yang X, Yang S, McKimmey C, Liu B, Edgerton SM, Bales W, Archer LT and Thor AD: Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation. Carcinogenesis. 31:695–702. 2010. View Article : Google Scholar : PubMed/NCBI
24	Yang X, Edgerton SM, Kosanke SD, Mason TL, Alvarez KM, Liu N, Chatterton RT, Liu B, Wang Q, Kim A, et al: Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res. 63:2425–2433. 2003.PubMed/NCBI
25	Warin R, Chambers WH, Potter DM and Singh SV: Prevention of mammary carcinogenesis in MMTV-neu mice by cruciferous vegetable constituent benzyl isothiocyanate. Cancer Res. 69:9473–9480. 2009. View Article : Google Scholar : PubMed/NCBI
26	Shen K and Novak RF: DDT stimulates c-erbB2, c-met, and STATS tyrosine phosphorylation, Grb2-Sos association, MAPK phosphorylation, and proliferation of human breast epithelial cells. Biochem Biophys Res Commun. 231:17–21. 1997. View Article : Google Scholar : PubMed/NCBI
27	Shan L, Yu M and Snyderwine EG: Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas. Toxicol Pathol. 33:768–775. 2005. View Article : Google Scholar : PubMed/NCBI
28	Shan L, He M, Yu M, Qiu C, Lee NH, Liu ET and Snyderwine EG: cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene. Carcinogenesis. 23:1561–1568. 2002. View Article : Google Scholar : PubMed/NCBI
29	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
30	Kim YM, Ma Z, Lee S, Lee J, Li S and Yang X: Trisomy chromosome 5 is a recurrent cytogenetic lesion in mammary tumors from parous MMTV-erbB-2 transgenic mice. Oncol Lett. 2:1077–1081. 2011. View Article : Google Scholar : PubMed/NCBI
31	de Oliveira Andrade F, Fontelles CC, Rosim MP, de Oliveira TF, de Melo Loureiro AP, Mancini-Filho J, Rogero MM, Moreno FS, de Assis S, Barbisan LF, et al: Exposure to lard-based high-fat diet during fetal and lactation periods modifies breast cancer susceptibility in adulthood in rats. J Nutr Biochem. 25:613–622. 2014. View Article : Google Scholar : PubMed/NCBI
32	Qin LQ, Xu JY, Tezuka H, Wang PY and Hoshi K: Commercial soy milk enhances the development of 7,12-dimethylbenz(a) anthracene-induced mammary tumors in rats. In Vivo. 21:667–671. 2007.PubMed/NCBI
33	Qi C, Lan H, Ye J, Li W, Wei P, Yang Y, Guo S, Lan T, Li J, Zhang Q, et al: Slit2 promotes tumor growth and invasion in chemically induced skin carcinogenesis. Lab Invest. 94:766–776. 2014. View Article : Google Scholar : PubMed/NCBI
34	Muller WJ, Sinn E, Pattengale PK, Wallace R and Leder P: Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell. 54:105–115. 1988. View Article : Google Scholar : PubMed/NCBI
35	Mohibi S, Mirza S, Band H and Band V: Mouse models of estrogen receptor-positive breast cancer. J Carcinog. 10:352011. View Article : Google Scholar : PubMed/NCBI
36	Cool M, Depault F and Jolicoeur P: Fine allelotyping of Erbb2-induced mammary tumors in mice reveals multiple discontinuous candidate regions of tumor-suppressor loci. Genes Chromosomes Cancer. 45:191–202. 2006. View Article : Google Scholar : PubMed/NCBI
37	Liu S, Liu W, Jakubczak JL, Erexson GL, Tindall KR, Chan R, Muller WJ, Adhya S, Garges S and Merlino G: Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis. Proc Natl Acad Sci USA. 99:3770–3775. 2002. View Article : Google Scholar : PubMed/NCBI
38	Daniel FB and Joyce NJ: DNA adduct formation by 7, 12-dimethylbenz[a]anthracene and its noncarcinogenic 2-fluoro analogue in female Sprague-Dawley rats. J Natl Cancer Inst. 70:111–118. 1983.PubMed/NCBI
39	Russo IH and Russo J: Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect. 104:938–967. 1996. View Article : Google Scholar : PubMed/NCBI
40	Umekita Y, Souda M, Hatanaka K, Hamada T, Yoshioka T, Kawaguchi H and Tanimoto A: Gene expression profile of terminal end buds in rat mammary glands exposed to diethylstilbestrol in neonatal period. Toxicol Lett. 205:15–25. 2011. View Article : Google Scholar : PubMed/NCBI
41	Hsu PY, Deatherage DE, Rodriguez BA, Liyanarachchi S, Weng YI, Zuo T, Liu J, Cheng AS and Huang TH: Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res. 69:5936–5945. 2009. View Article : Google Scholar : PubMed/NCBI
42	Lamartiniere CA, Jenkins S, Betancourt AM, Wang J and Russo J: Exposure to the endocrine disruptor bisphenol a alters susceptibility for mammary cancer. Horm Mol Biol Clin Investig. 5:45–52. 2011.PubMed/NCBI
43	Wogan GN, Hecht SS, Felton JS, Conney AH and Loeb LA: Environmental and chemical carcinogenesis. Semin Cancer Biol. 14:473–486. 2004. View Article : Google Scholar : PubMed/NCBI
44	Medina D: Chemical carcinogenesis of rat and mouse mammary glands. Breast Dis. 28:63–68. 2007. View Article : Google Scholar : PubMed/NCBI
45	Plante I, Stewart MK, Barr K, Allan AL and Laird DW: Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease. Oncogene. 30:1681–1692. 2011. View Article : Google Scholar : PubMed/NCBI
46	Russo J and Russo IH: Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res. 40:2677–2687. 1980.PubMed/NCBI
47	Markey CM, Luque EH, Munoz De Toro M, Sonnenschein C and Soto AM: In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod. 65:1215–1223. 2001. View Article : Google Scholar : PubMed/NCBI
48	Coffey RJ Jr, Meise KS, Matsui Y, Hogan BL, Dempsey PJ and Halter SA: Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene. Cancer Res. 54:1678–1683. 1994.PubMed/NCBI